ClinicalTrials.gg
Status unknownNCT03488602FSPSUpdated Apr 5, 2018

Focused Suicide Prevention Strategy for Youth

An interventional study of F-SPS+UC and EUC in Suicide, Suicide, Attempted and Suicidal Ideation, sponsored by The Hospital for Sick Children. Status unknown at 1 site in Canada. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2018-04-05.

Primary conditionSuicide, AttemptedRegistry: SuicideReclassifiedWhy we changed it
Registry
Suicide — the first condition term the registry derived for this study.
ClinicalTrials.gg
Suicide, Attempted
Why
  1. Suicide is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Suicide, Attempted, a narrower term within Suicide.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by The Hospital for Sick Children · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
128
Allocation
Randomized
Ages
12 Years to 18 Years
Sex
All
01

Study summary

This study evaluates whether a Family-centered suicide prevention strategy, when added to usual care (F-SPS + UC), is more effective than enhanced usual care (EUC) in reducing suicide-related behaviors in 128 youth at high-risk of suicide. Half of the participants will be randomized to receive F-SPS + UC and half will receive EUC.

Read the detailed description

This is a RCT of a patient- and family-centered suicide prevention intervention added to usual care (F-SPS + UC) for adolescents aged 12 to 18 years who present to the Emergency Department (ED) with suicidal ideation or suicide risk behaviours. The investigators will determine whether the F-SPS + UC intervention is more effective than enhanced usual care (EUC) in reducing suicide-related behaviors in 128 youth at high-risk of suicide.

F-SPS is a 6-week, standardized, manualized outpatient program that teaches participants to the skills to manage suicidal thoughts and impulses effectively. The family component addresses conflictual relationships that may be present in the family as well as improving family communication.

Enhanced usual care consists of 6 weekly telephone calls to ensure that the participant has connected with community resources suggested by the ED team and provide additional resources as needed.

02

Conditions studied

  • Suicide
  • Suicide, Attempted
  • Suicidal Ideation

Browse trials for

03

In context

Suicide, Attempted Reclassified

281 studies on the registry are indexed under Suicide, Attempted; 91 are open to participants now.

This study's planned enrollment of 128 is close to the median of 129 across 224 interventional studies indexed under Suicide, Attempted.

Browse Suicide, Attempted studies →

Lead sponsor

The Hospital for Sick Children is the lead sponsor of 578 studies on the registry; 83 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.

Compared within Suicide, Attempted, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Suicide. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ages 12 to18 years
  • Youth presenting in the Emergency Department with acute suicidal ideation or suicide risk behaviour
  • SIQ-Jr score ≥ 31
  • Parent or caregiver able to communicate in English, or is willing to communicate using a hospital-organized translator, and willing to participate in study
  • Living in the greater Toronto area and access to a telephone.

Exclusion criteria

Exclusion Criteria:

  • Active psychosis or hypomania/mania
  • Moderate to severe intellectual disability, autism.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
128 participants (estimated)

Study arms

  • Experimental
    F-SPS Intervention

    This group will receive the F-SPS intervention.

    Behavioral: F-SPS+UC

  • Active comparator
    Enhanced Usual Care (EUC)

    This group will receive Enhanced Usual Care (EUC)

    Behavioral: EUC

Interventions

  • BehavioralF-SPS+UC

    Manualized individual and family program. Weekly individual and family sessions with a therapist for 6 weeks. Participants will continue to receive usual care.

    Also known as: F-SPS + UC

  • BehavioralEUC

    Weekly telephone contact with parents regarding participant health care utilization. Referrals to community mental health resources provided as needed. Participants will continue to receive usual care.

06

What researchers measure

Primary outcomes

  1. Change in suicidal ideation severity as measured by the Suicidal Ideation Questionnaire - Jr

    a 15-item measure self-report of suicide ideation (e.g., thoughts about death and dying) completed by the patient. Items are scored from 0 to 6, yielding a score from 0 to 90. Higher scores indicate more severe suicidal ideation.

    Time frame: Screening, 6 weeks, 24 weeks

Secondary outcomes

  1. Change in suicide related behavior as measured by the Suicide Behavior Questionnaire - Revised

    A 4-item self-report questionnaire that measures suicide behavior, and yields a total score of 3 - 18. Higher scores indicate more severe suicidal behavior.

    Time frame: Screening, 6 weeks, 24 weeks

  2. Changes in emotional regulation using the Life Problems Inventory

    A 60-item self-report scale that measures emotional regulation on a 5 point Likert scale from 1 to 5. Higher scores indicate more impaired emotional regulation. The measure has four subscales: Confusion about Self, Impulsivity, Emotion Dysregulation, and Interpersonal Chaos. Each subscale has a score from 15 to 75 where a higher score indicates more severity.

    Time frame: Baseline, 6 weeks, 24 weeks

  3. Change in family conflict as measured by the Conflict Behavior Questionnaire

    A 20-item scale that examines the parent-child relationship using true/false ratings, yielding a total score of 0 to 20. Higher scores This measure is completed by both the youth and the parent(s) or caregiver. Higher scores indicate more severe family conflict.

    Time frame: Baseline, 6 weeks, 24 weeks

  4. Changes in global impairment as measured by the Columbia Impairment Scale

    A 13-item scale designed to measure functioning on a 5 point Likert scale from 0 to 4, yielding a total score of 0 to 52. This measure is completed by both the youth and the parent(s) or caregiver. Higher scores indicate more severe impairment.

    Time frame: Baseline, 6 weeks, 24 weeks

  5. Changes in affect regulation as measured by the Children's Affective Lability Scale

    A 20-item parent-report instrument that measures difficulties with emotion regulation on 5 point Likert scale from 0 to 4, yielding a score from 0 to 80. Higher scores indicate more severe affective lability.

    Time frame: Baseline, 6 weeks, 24 weeks

  6. Health Care Utilization Survey

    A parent-report qualitative interview of a youth's use of available health care services, medication, and the costs associated with those services.

    Time frame: Baseline, 24 weeks

  7. Usual Care Tracking Survey

    A parent-report qualitative interview of a youth's use of available health care services over a 1 week period of time.

    Time frame: Week 1, Week 2, Week 3, Week 4, Week 5, Week 6

07

Study locations

1 of 1 sites recruiting
  • Matthew Tracey
    Toronto, Ontario M5G 1X8, Canada
    Recruiting
    • Matthew Tracey, MA · Contactmatthew.tracey@sickkids.ca · 4165358501
    • Reva Schachter, MSc · Contactreva.schachter@sickkids.ca · 4165358501
    • Daphne J Korczak, MD, Msc · Principal investigator
    • Yaron Finkelstein, MD · Principal investigator
    • Melanie Barwick, PhD · Sub investigator
    • Peter Szatmari, MD · Sub investigator
    • Kristin Cleverly, PhD · Sub investigator
    • Gloria Chaim, MSW · Sub investigator
    • Joanna Henderson, PhD · Sub investigator
    • Suneeta Monga, MD · Sub investigator
    • David Juurlink, MD · Sub investigator
    • Myla Moretti, PhD · Sub investigator
08

References and documents

Publications

  • Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2. PubMed 33884617 ↗
  • Tracey M, Finkelstein Y, Schachter R, Cleverley K, Monga S, Barwick M, Szatmari P, Moretti ME, Willan A, Henderson J, Korczak DJ. Recruitment of adolescents with suicidal ideation in the emergency department: lessons from a randomized controlled pilot trial of a youth suicide prevention intervention. BMC Med Res Methodol. 2020 Sep 14;20(1):231. doi: 10.1186/s12874-020-01117-5. PubMed 32928140 ↗
  • Korczak DJ, Finkelstein Y, Barwick M, Chaim G, Cleverley K, Henderson J, Monga S, Moretti ME, Willan A, Szatmari P. A suicide prevention strategy for youth presenting to the emergency department with suicide related behaviour: protocol for a randomized controlled trial. BMC Psychiatry. 2020 Jan 14;20(1):20. doi: 10.1186/s12888-019-2422-y. PubMed 31937274 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2018 (actual). Primary completion is estimated for Feb 2020, 23 months after the start.

Of 145 non-industry interventional studies with no phase under Suicide, Attempted, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 56. This study's planned 23 months is below that.

Counting every sponsor, half of 147 studies reached it within 37 months; a quarter within 20 and three quarters within 56.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 8, 2018
First posted
Apr 5, 2018
StartActual
Mar 1, 2018
Primary completionEst.
Feb 2020
CompletionEst.
Jul 2020
Last update
Apr 5, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 5, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03488602
Collaborators
The Cundill Centre for Child and Youth Depression, SickKids Foundation
Responsible party
Daphne Korczak (Psychiatrist, The Hospital for Sick Children) — Principal investigator
First posted
Apr 5, 2018
Start date
Mar 1, 2018
Primary completion
Feb 2020 (estimated)
Completion
Jul 2020 (estimated)
Last update
Apr 5, 2018

Study contacts

Matthew Tracey, MA
Contact
matthew.tracey@sickkids.ca
4165358501 ext. 201575
Reva Schachter, MSc
Contact
reva.schachter@sickkids.ca
4165358501 ext. 201469
Daphne J Korczak, MD, MSc
principal investigator · The Hospital for Sick Children

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion